Health In Tech, Inc.
corporate_fare Company Profile
Health In Tech, Inc. (NASDAQ:HIT) is a publicly traded company in the Finance sector. Wiseek has independently scored 33 items for HIT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 8 rated 8 or above. Recent SEC coverage for HIT spans 10-Q, 8-K, DEFA14A, 424B3.
Recent high-impact activity:
- Health In Tech 10-Q: $6.1M Credit-Loss Charge Drives $11.2M Nine-Month Net Loss
- Health In Tech Q3 Call: $32.7M Contracted Revenue, $156.4M Pipeline, FY26 Outlook ~$30M
- Q3 Revenue Falls 22% and Net Loss Hits $7.1M as FY2026 Outlook Cut to ~$30M
- Health In Tech Shareholders Approve 720M Authorized Shares and Yorkville Over-20% Issuance
- Health In Tech Draws Second $3.0M Yorkville Note at $1.5735 Conversion Price
Financial Snapshot
Short Interest & Short Volume
10.34 days to coverFINRA reported short interest of 602,449 shares in HIT as of the October 30, 2026 settlement, a 42.3% increase from the prior period — about 10.3 days to cover at its recent average daily volume. On November 20, 2026, 22.4% of HIT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for HIT, detected from its recent SEC filings · based on capital-structure filings through 2026-10-10.
SEPA Registration Amended to 34.2M Shares · $15M Convertible Note Terms Disclosed
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →